Clinical trial
An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON…
NCT00250250 · Ferring Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00250250 |
|---|---|
| Title | An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MG |
| Official title | An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MG (Recombinant Somatropin) Administered by ZomaJet Vision X |
| Lead sponsor | Ferring Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Turner's Syndrome |
| Intervention type | Drug |
| Interventions | ZOMACTON |
| Enrollment | 27 |
| Start date | Oct 1, 2005 |
| Primary completion | Mar 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Nov 8, 2005 |
| Last update posted | May 20, 2011 |
| Countries | Czechia, France, Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: